CMA To Probe $295M Roche Diagnostics Deal
Britain's antitrust regulator said Friday that it has decided to launch a probe into Swiss drugmaker Roche's proposed $295 million purchase of parts of diagnostic company LumiraDx days after inviting public...To view the full article, register now.
Already a subscriber? Click here to view full article